SI0989972T1 - Prostaglandin pharmaceutical compositions - Google Patents

Prostaglandin pharmaceutical compositions

Info

Publication number
SI0989972T1
SI0989972T1 SI9830313T SI9830313T SI0989972T1 SI 0989972 T1 SI0989972 T1 SI 0989972T1 SI 9830313 T SI9830313 T SI 9830313T SI 9830313 T SI9830313 T SI 9830313T SI 0989972 T1 SI0989972 T1 SI 0989972T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical compositions
prostaglandin
prostaglandin pharmaceutical
compounds
general formula
Prior art date
Application number
SI9830313T
Other languages
English (en)
Slovenian (sl)
Inventor
Soldato Piero Del
Original Assignee
Nicox S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox S.A. filed Critical Nicox S.A.
Publication of SI0989972T1 publication Critical patent/SI0989972T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
SI9830313T 1997-06-19 1998-06-17 Prostaglandin pharmaceutical compositions SI0989972T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT97MI001440A IT1292377B1 (it) 1997-06-19 1997-06-19 Composizioni farmaceutiche a base di prostaglandine
EP98934967A EP0989972B1 (en) 1997-06-19 1998-06-17 Prostaglandin pharmaceutical compositions
PCT/EP1998/003645 WO1998058910A1 (en) 1997-06-19 1998-06-17 Prostaglandin pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SI0989972T1 true SI0989972T1 (en) 2003-04-30

Family

ID=11377397

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830313T SI0989972T1 (en) 1997-06-19 1998-06-17 Prostaglandin pharmaceutical compositions

Country Status (19)

Country Link
US (1) US6211233B1 (enExample)
EP (1) EP0989972B1 (enExample)
JP (1) JP4394170B2 (enExample)
KR (1) KR20010013625A (enExample)
CN (1) CN1260778A (enExample)
AT (1) ATE225771T1 (enExample)
AU (1) AU740683B2 (enExample)
BR (1) BR9810163B1 (enExample)
CA (1) CA2292836C (enExample)
DE (1) DE69808619T2 (enExample)
DK (1) DK0989972T3 (enExample)
ES (1) ES2185188T3 (enExample)
HU (1) HUP0004071A3 (enExample)
IL (1) IL132690A (enExample)
IT (1) IT1292377B1 (enExample)
PT (1) PT989972E (enExample)
RU (1) RU2000100807A (enExample)
SI (1) SI0989972T1 (enExample)
WO (1) WO1998058910A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU3713600A (en) 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
IT1311923B1 (it) 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
AU2002243795A1 (en) * 2001-01-30 2002-08-12 Pharmaceutical Research Corporation Use of prostaglandin analogs for treatment of cardiac conditions
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
BR0307420A (pt) * 2002-02-04 2004-12-21 Werner Haas Compostos, composições farmacêuticas e métodos para impedir e/ou tratar doença em mamìfero
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
KR100854838B1 (ko) * 2004-01-05 2008-08-29 니콕스 에스. 에이. 프로스타글란딘 나이트로옥시 유도체
WO2007000642A1 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Fluoroprostaglandins nitroderivatives
WO2007000641A2 (en) * 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
CA2647859C (en) 2006-03-29 2016-01-05 Nitromed, Inc. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
US8041859B2 (en) * 2007-11-05 2011-10-18 Honywell International Inc. Apparatus and method for connectivity in networks capable of non-disruptively disconnecting peripheral devices
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
US9844599B2 (en) 2013-01-21 2017-12-19 Apparao Satyam Nitric oxide releasing produgs of therapeutic agents
CN119350280A (zh) * 2021-11-18 2025-01-24 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
CN116178233A (zh) * 2023-02-27 2023-05-30 广州楷石生物科技有限公司 伊洛前列素一氧化氮供体药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3371199D1 (en) * 1982-08-24 1987-06-04 Teijin Ltd Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
IT1243367B (it) 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
US5352708A (en) 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5328933A (en) 1992-10-28 1994-07-12 Allergan, Inc. Cyclopentane heptenylnitro and heptanylnitro-2-aliphatic or aryl aliphatic derivatives and homologues
ES2139199T3 (es) * 1994-05-10 2000-02-01 Nicox Sa Compuestos nitro y composiciones que los contienen que presentan una actividad anti-inflamatoria, analgesica y antitrombotica.
US5625083A (en) * 1995-06-02 1997-04-29 Bezuglov; Vladimir V. Dinitroglycerol esters of unsaturated fatty acids and prostaglandins

Also Published As

Publication number Publication date
JP2002506440A (ja) 2002-02-26
EP0989972A1 (en) 2000-04-05
ITMI971440A1 (it) 1998-12-19
PT989972E (pt) 2003-02-28
KR20010013625A (ko) 2001-02-26
ES2185188T3 (es) 2003-04-16
HUP0004071A2 (hu) 2001-04-28
EP0989972B1 (en) 2002-10-09
WO1998058910A1 (en) 1998-12-30
BR9810163B1 (pt) 2009-01-13
BR9810163A (pt) 2000-08-08
DK0989972T3 (da) 2003-02-10
ATE225771T1 (de) 2002-10-15
AU8438698A (en) 1999-01-04
DE69808619T2 (de) 2003-06-12
IT1292377B1 (it) 1999-02-08
IL132690A0 (en) 2001-03-19
IL132690A (en) 2004-06-01
RU2000100807A (ru) 2002-02-27
US6211233B1 (en) 2001-04-03
AU740683B2 (en) 2001-11-08
JP4394170B2 (ja) 2010-01-06
ITMI971440A0 (enExample) 1997-06-19
CA2292836C (en) 2010-03-02
CN1260778A (zh) 2000-07-19
DE69808619D1 (de) 2002-11-14
HUP0004071A3 (en) 2002-12-28
CA2292836A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
IL132690A0 (en) Prostaglandin pharmaceutical compositions
BG103485A (en) Ketobanzamides as calpain inhibitors
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
HN1998000036A (es) Compuesto de pirazina
DK0941218T3 (da) Antithrombotiske organiske nitrater
PT1193270E (pt) Pirrolobenzodiazepinas
BG106340A (en) Substituted oxoazaheterocyclyl compounds
WO1999002514A3 (en) Epothilone derivatives
YU56995A (sh) Soli derivata indola
BR0014651A (pt) Inibidores de adesão de célula mediada por "alfa" l beta2
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
AU674378B2 (en) Use of 2-amino-6-A-propylamino-4,5,6, 7-tetrahydrobenzothiazole (pramipexol) as an anti-depressantdrug
MX9604368A (es) Antagonistas de receptores de endotelina.
SE9801494D0 (sv) Novel use
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
MX9801190A (es) Inhibidores de prolil endopeptidasa.
PL367774A1 (en) Synthesis and intermediates
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
PT980354E (pt) Analogos de vitamina d3 com cadeias laterais bis-c-20
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
GT199900160A (es) Compuestos plaguicidas de bis-oxima.
AR005042A1 (es) Procedimiento para la preparacion de un antagonista endotelin.